Acutaas Chemicals Ltd.

•

acutaas.comBSE: 543349NSE: ACUTAAS

Market Cap₹ 26,194 Cr.

Current Price

High / Low₹ 3,740 / 1,302

Stock P/E67.8

Book Value₹ 211

Price to Book12.69

Dividend Yield0.08 %

ROCE32.4 %

ROE24.1 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 45.8% CAGR over last 5 years
Company is almost debt free
Company has a healthy return on capital (ROCE) of 21.5%
Company has consistently been profitable over the last 5 years
Latest quarter profit grew 70.4% YoY, showing strong momentum
Company has delivered good sales growth of 31.5% CAGR over last 5 years

CONS

Promoter holding has decreased over last 2 years: -3.3pp
Total debt has risen sharply - up 223.7% year on year
Stock is trading at 12.7x its book value
Equity base is being diluted - shares outstanding up 12.3%
Though reporting repeated profits, the company pays out little dividend (5.7%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ACUTAAS	3199.45	67.82	26194.26	0.08	74.99	70.40	329.68	59.08	32.42	34.30

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	154	172	166	225	177	247	275	308	207	306	393	433	330
	120	148	140	182	147	198	206	224	156	211	243	249	228
Operating Profit	34	25	27	43	30	49	69	85	51	95	151	184	102
OPM %	22.12%	14.40%	15.93%	19.19%	16.71%	19.83%	24.97%	27.54%	24.57%	31.13%	38.32%	42.41%	30.97%
	1	-30	3	1	1	8	2	6	16	10	5	11	2
Interest	1	1	3	2	4	0	1	1	1	1	1	1	1
Depreciation	4	4	4	5	6	7	6	7	8	8	10	10	10
Profit before Tax	31	-10	24	37	20	50	63	83	58	96	145	184	104
Tax %	28.12%	-71.23%	24.85%	30.99%	26.40%	24.92%	28.25%	24.29%	24.23%	25.29%	26.58%	26.94%	27.83%
Net Profit	0	0	0	0	15	38	45	63	44	72	106	134	75
	6.10	-4.67	4.58	3.43	1.83	4.69	5.68	7.80	5.41	8.82	13.19	16.09	9.07

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	160	188	239	240	341	520	617	717	1,007	1,339	1,462
	137	158	196	199	260	415	494	589	775	859	930
Operating Profit	23	31	42	41	80	105	123	128	232	480	532
OPM %	14.43%	16.21%	17.64%	17.12%	23.53%	20.22%	19.88%	17.91%	23.05%	35.87%	36.37%
	0	3	0	3	1	3	4	-25	17	42	27
Interest	3	3	5	6	6	6	2	6	6	3	4
Depreciation	1	2	3	4	4	10	12	16	27	36	38
Profit before Tax	19	28	35	35	72	91	112	82	216	483	529
Tax %	35.51%	34.75%	33.65%	20.96%	24.72%	21.33%	25.75%	40.53%	25.79%	26.18%	26.72%
Net Profit	12	18	23	27	54	72	83	49	160	356	387
EPS	80.32	123.30	7.40	8.72	17.14	21.03	22.86	11.60	19.39	43.51	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	15.19%	13.12%	25.87%	7.74%	5.75%	—

COMPOUNDED SALES GROWTH

10 Years:: 24%
5 Years:: 32%
3 Years:: 29%

COMPOUNDED PROFIT GROWTH

10 Years:: 40%
5 Years:: 46%
3 Years:: 62%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 122%

RETURN ON EQUITY

10 Years:: 26%
5 Years:: 17%
3 Years:: 16%
Last Year:: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	10	10	32	36	36	37	41	41
Minority Interest	0	0	0	0	0	0	0	9	10	57
	37	56	72	101	135	486	558	635	1,269	1,610
	24	41	48	54	117	1	3	186	13	36
Trade Payables	38	48	68	51	85	118	142	135	156	154
	8	9	14	15	44	18	28	95	60	87
Total Liabilities	109	155	213	232	413	659	767	1,096	1,549	1,984
	28	32	79	85	186	205	259	427	570	745
Capital Work in Progress	11	30	2	12	0	2	26	125	130	332
	1	3	2	2	1	2	2	0	0	0
	20	27	39	52	60	112	119	157	180	231
	0	0	0	0	0	0	0	206	290	363
Cash & Bank	4	1	0	4	3	100	59	53	249	225
	45	62	92	77	162	239	303	127	129	88
Total Assets	109	155	213	232	413	659	767	1,096	1,549	1,984

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	35	16	29	35	42	11	90	125	118	292
Cash from Investing	-19	-25	-21	-24	-101	-121	-33	-365	-224	-266
Cash from Financing	-7	15	6	0	72	140	-12	239	261	4
	3	-2	-0	3	-1	8	20	-1	156	30

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	80.32	123.73	22.19	26.16	17.14	19.75	22.86	11.60	19.39	43.51
Book Value (₹)	259.14	372.75	74.83	100.85	51.03	143.34	163.01	182.13	159.95	201.59
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	3.00	3.00	3.00	1.50	2.50
Cash EPS (₹)	2.13	3.24	4.11	4.92	3.08	11.26	13.12	8.78	11.42	47.92
PROFITABILITY
Operating Margin %	14.57%	17.79%	17.80%	18.30%	23.94%	20.75%	20.58%	17.91%	23.05%	35.87%
Net Margin %	7.52%	9.83%	9.77%	11.46%	15.85%	13.83%	13.50%	6.79%	15.93%	26.61%
ROE %	36.44%	39.03%	34.64%	29.78%	40.51%	21.07%	14.92%	7.70%	16.19%	24.08%
ROCE %	35.91%	38.24%	34.33%	27.09%	33.43%	23.85%	20.45%	11.81%	20.14%	32.42%
	12.04%	13.99%	12.64%	12.34%	16.74%	13.42%	11.68%	5.23%	12.13%	20.17%
EFFICIENCY
Debtor Days	83	84	96	101	95	100	117	111	90	89
Inventory Days	45	46	51	69	60	61	68	70	61	56
Payable Days	128	139	143	170	138	136	144	123	96	100
	-1	-10	4	1	17	24	41	59	55	45
FINANCIAL HEALTH
Debt to Equity (x)	0.68x	0.78x	0.69x	0.56x	0.85x	0.00x	0.01x	0.32x	0.01x	0.02x
Interest Coverage (x)	6.67x	9.79x	8.39x	7.22x	13.77x	15.27x	47.50x	14.79x	35.76x	148.71x
	1.21x	1.34x	1.18x	1.28x	1.30x	3.32x	2.81x	1.73x	3.91x	3.82x
GROWTH
Revenue Growth %	4.27%	17.45%	26.72%	0.47%	42.13%	52.71%	18.57%	16.33%	40.34%	33.02%
Operating Profit Growth %	10.86%	43.40%	26.85%	3.29%	85.90%	32.39%	17.59%	7.13%	83.12%	109.63%
Net Profit Growth %	-4.80%	53.51%	25.95%	17.92%	96.57%	33.24%	15.77%	-41.52%	229.35%	122.15%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-49.26%	67.16%	124.46%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	47.18x	62.97x	58.79x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	6.01x	15.26x	12.69x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.27%	0.06%	0.10%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	30.88x	79.31x	39.75x

Shareholding Pattern

Numbers in percentages

Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
35.98	35.97	35.96	35.96	32.66	32.66	32.66	32.66	32.66
12.93	13.87	15.52	16.48	16.94	16.84	16.67	19.48	21.61
14.81	19.93	20.23	18.31	22.38	22.59	21.70	19.60	19.55
0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01
36.29	30.23	28.27	29.23	28.01	27.89	28.96	28.24	26.16

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

General Updates

2026-09-04 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-31

Copy of Newspaper Publication

2026-08-31 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29

General Updates

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-29

Record Date

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Sep-2026.

2026-08-29

Shareholders meeting

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-28

Press Release

2026-08-28 - Acutaas Chemicals Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Acutaas Chemicals step-down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju, The Republic of Korea".

2026-08-24

Copy of Newspaper Publication

2026-08-24 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-22

General Updates

2026-08-22 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-18

General Updates

2026-08-18 - Acutaas Chemicals Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for ACUTAAS

Loading news…

🤖

AI Stock Analyst

Acutaas Chemicals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account